The control of endotoxins in pharmaceutical products is imperative due to the varying level of immune responses incurred when introduced in to the blood stream.
Manufacturers of all parenteral drugs must ensure appropriate control, testing and removal methods are in place throughout the process to assure patient safety.
As the processes within quality control evolve, so do the endotoxin control methods and it essential to choose the right processes for your company to appropriately deal with the issue.
This workshop will give an overview of identifying an appropriate approach to address LER, calculating risk for contamination and a holistic approach to address the impurities.